← Evidence map

SynthesisJournal of gastrointestinal cancer2024

Atezolizumab and Bevacizumab Targeted-Therapy in Advanced Hepatocellular Carcinoma: A Systematic Review of Cost-effectiveness Analyses.

Ghader Mohammadnezhad et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2024
2025
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38488933